181 related articles for article (PubMed ID: 30235109)
21. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine.
Aklillu E; Habtewold A; Ngaimisi E; Yimer G; Mugusi S; Amogne W; Reuter T; Meid A; Hoffmann MM; Weiss J
OMICS; 2016 Sep; 20(9):538-45. PubMed ID: 27631193
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the genetic profile of CYP2C19 in two South African populations.
Drögemöller BI; Wright GE; Niehaus DJ; Koen L; Malan S; Da Silva DM; Hillermann-Rebello R; La Grange AM; Venter M; Warnich L
Pharmacogenomics; 2010 Aug; 11(8):1095-103. PubMed ID: 20712527
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of COMT gene polymorphisms in North African populations.
Boussetta S; Cherni L; Pakstis AJ; Ben Salem N; Elkamel S; Khodjet-El-Khil H; Kidd KK; Elgaaied ABA
Gene; 2019 May; 696():186-196. PubMed ID: 30790653
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of
Ford GR; Niehaus A; Joubert F; Pepper MS
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556234
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci.
Cao K; Moormann AM; Lyke KE; Masaberg C; Sumba OP; Doumbo OK; Koech D; Lancaster A; Nelson M; Meyer D; Single R; Hartzman RJ; Plowe CV; Kazura J; Mann DL; Sztein MB; Thomson G; Fernández-Viña MA
Tissue Antigens; 2004 Apr; 63(4):293-325. PubMed ID: 15009803
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations.
Paximadis M; Picton ACP; Sengupta D; Ramsay M; Puren A; Tiemessen CT
Cytokine; 2021 Jul; 143():155489. PubMed ID: 33814271
[TBL] [Abstract][Full Text] [Related]
27. CEPH individuals are representative of the European American population: implications for pharmacogenetics.
Meucci MA; Marsh S; Watters JW; McLeod HL
Pharmacogenomics; 2005 Jan; 6(1):59-63. PubMed ID: 15723606
[TBL] [Abstract][Full Text] [Related]
28. A pharmacogenetic study of CD4 recovery in response to HIV antiretroviral therapy in two South African population groups.
Parathyras J; Gebhardt S; Hillermann-Rebello R; Grobbelaar N; Venter M; Warnich L
J Hum Genet; 2009 May; 54(5):261-5. PubMed ID: 19282874
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
Čolić A; Alessandrini M; Pepper MS
Drug Metab Rev; 2015 May; 47(2):111-23. PubMed ID: 25391641
[TBL] [Abstract][Full Text] [Related]
30. SLC22A2 - mapping genomic variations within South African indigenous and admixed populations.
Pearce B; Jacobs C; Hoosain N; Benjeddou M
Drug Metab Pers Ther; 2016 Dec; 31(4):213-220. PubMed ID: 27828777
[TBL] [Abstract][Full Text] [Related]
31. Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.
Oliveira E; Pereira R; Amorim A; McLeod H; Prata MJ
Pharmacogenomics; 2009 Sep; 10(9):1413-22. PubMed ID: 19761365
[TBL] [Abstract][Full Text] [Related]
32. 5-HTTLPR polymorphism: analysis in South African autistic individuals.
Arieff Z; Kaur M; Gameeldien H; van der Merwe L; Bajic VB
Hum Biol; 2010 Jun; 82(3):291-300. PubMed ID: 20649385
[TBL] [Abstract][Full Text] [Related]
33. An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.
Soko ND; Chimusa E; Masimirembwa C; Dandara C
Pharmacogenomics J; 2019 Jun; 19(3):240-248. PubMed ID: 30100615
[TBL] [Abstract][Full Text] [Related]
34. Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region.
Mestiri S; Boussetta S; Pakstis AJ; Elkamel S; Elgaaied ABA; Kidd KK; Cherni L
Gene; 2021 Apr; 777():145466. PubMed ID: 33524518
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics of Rosuvastatin: A Glocal (Global+Local) African Perspective and Expert Review on a Statin Drug.
Soko ND; Masimirembwa C; Dandara C
OMICS; 2016 Sep; 20(9):498-509. PubMed ID: 27631189
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences.
Camara MD; Zhou Y; De Sousa TN; Gil JP; Djimde AA; Lauschke VM
Hum Genomics; 2024 Apr; 18(1):40. PubMed ID: 38650020
[TBL] [Abstract][Full Text] [Related]
37. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.
Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R
S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689
[TBL] [Abstract][Full Text] [Related]
38. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.
Ameyaw MM; Regateiro F; Li T; Liu X; Tariq M; Mobarek A; Thornton N; Folayan GO; Githang'a J; Indalo A; Ofori-Adjei D; Price-Evans DA; McLeod HL
Pharmacogenetics; 2001 Apr; 11(3):217-21. PubMed ID: 11337937
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics, ancestry and clinical decision making for global populations.
Ramos E; Doumatey A; Elkahloun AG; Shriner D; Huang H; Chen G; Zhou J; McLeod H; Adeyemo A; Rotimi CN
Pharmacogenomics J; 2014 Jun; 14(3):217-22. PubMed ID: 23835662
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D; Peng L; Xing S; He C; Jin T
BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
